These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 28938271)
21. [Does the new UICC classification allow better prognostic assessment for ductal pancreatic carcinoma?]. Ott K; Böttcher K; Werner M; Busch R; Roder JD Chirurg; 2000 Feb; 71(2):189-95. PubMed ID: 10734588 [TBL] [Abstract][Full Text] [Related]
22. Extended lymphadenectomy in the surgery of pancreatic adenocarcinoma and its relation to quality improvement issues. Rupp CC; Linehan DC J Surg Oncol; 2009 Mar; 99(4):207-14. PubMed ID: 19072980 [TBL] [Abstract][Full Text] [Related]
23. Can Neoadjuvant Therapy in Pancreatic Cancer Increase the Pool of Patients Eligible for Pancreaticoduodenectomy? Hackert T; Ulrich A; Büchler MW Adv Surg; 2017 Sep; 51(1):1-10. PubMed ID: 28797331 [No Abstract] [Full Text] [Related]
24. Clinical Significance of Intraoperative Frozen Section Analysis of Pancreatic Cancer Surgical Margin at the Time of Pancreaticoduodenectomy. Bender O; Bozkurt S; Buyukpinarbasili N; Malya FÜ; Battal M; Karatepe O Chirurgia (Bucur); 2015; 110(5):446-50. PubMed ID: 26531788 [TBL] [Abstract][Full Text] [Related]
25. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis. Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792 [TBL] [Abstract][Full Text] [Related]
26. Usefulness of Japanese staging in the prognosis of patients treated operatively for adenocarcinoma of the head of the pancreas. Kobari M; Sunamura M; Ohashi O; Saitoh Y; Yusa T; Matsuno S J Am Coll Surg; 1996 Jan; 182(1):24-32. PubMed ID: 8542085 [TBL] [Abstract][Full Text] [Related]
27. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors. El Nakeeb A; El Sorogy M; Ezzat H; Said R; El Dosoky M; Abd El Gawad M; Elsabagh AM; El Hanafy E Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):443-449. PubMed ID: 30126828 [TBL] [Abstract][Full Text] [Related]
28. Pancreaticoduodenectomy for periampullary adenocarcinoma. Andersen HB; Baden H; Brahe NE; Burcharth F J Am Coll Surg; 1994 Nov; 179(5):545-52. PubMed ID: 7952456 [TBL] [Abstract][Full Text] [Related]
29. [Oncologic risk in pylorus preservation in resection of ductal pancreas carcinoma]. Gerdes B; Ramaswamy A; Bartsch D; Rothmund M Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1087-9. PubMed ID: 9574341 [TBL] [Abstract][Full Text] [Related]
30. Nontherapeutic celiotomy incidence is not affected by volume of pancreaticoduodenectomy for pancreatic adenocarcinoma. Toomey P; Childs C; Luberice K; Ross S; Rosemurgy A Am Surg; 2013 Aug; 79(8):781-5. PubMed ID: 23896244 [TBL] [Abstract][Full Text] [Related]
31. Does the extent of lymphadenectomy have impact on the prognosis of patients with pancreatic cancer? Henne-Bruns D; Vogel I Onkologie; 2002 Feb; 25(1):69-71. PubMed ID: 11928695 [No Abstract] [Full Text] [Related]
32. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas. Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N Hepatogastroenterology; 2006; 53(69):447-51. PubMed ID: 16795990 [TBL] [Abstract][Full Text] [Related]
33. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190 [TBL] [Abstract][Full Text] [Related]
34. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer. Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422 [TBL] [Abstract][Full Text] [Related]
35. Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters. Addeo P; Velten M; Averous G; Faitot F; Nguimpi-Tambou M; Nappo G; Felli E; Fuchshuber P; Bachellier P Surgery; 2017 Aug; 162(2):264-274. PubMed ID: 28576385 [TBL] [Abstract][Full Text] [Related]
36. Survival advantage with para aortic lymphadenectomy in peri-ampullary cancer: A retrospective cohort study. Hafeez Bhatti AB; Dar FS; Sahaab E; Khan NY; Zia H; Rana A; Salih M; Shah NH Int J Surg; 2016 Jul; 31():58-62. PubMed ID: 27262530 [TBL] [Abstract][Full Text] [Related]
37. The natural history of resected pancreatic cancer without adjuvant chemotherapy. Hernandez JM; Morton CA; Al-Saadi S; Villadolid D; Cooper J; Bowers C; Rosemurgy AS Am Surg; 2010 May; 76(5):480-5. PubMed ID: 20506876 [TBL] [Abstract][Full Text] [Related]
38. Morbidity among long-term survivors after pancreatoduodenectomy for pancreatic adenocarcinoma. Chen KT; Devarajan K; Hoffman JP Ann Surg Oncol; 2015 Apr; 22(4):1185-9. PubMed ID: 25384699 [TBL] [Abstract][Full Text] [Related]
39. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer]. Roder JD; Siewert JR Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655 [TBL] [Abstract][Full Text] [Related]
40. Survival among pancreaticoduodenectomy patients treated for pancreatic head cancer <1 or 2 cm. Franko J; Hugec V; Lopes TL; Goldman CD Ann Surg Oncol; 2013 Feb; 20(2):357-61. PubMed ID: 22941171 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]